Split History
ETFs Holding AGE »    AGE Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AgeX Therapeutics is a biotechnology company focused on the development and commercialization of therapeutics targeting human aging and degenerative diseases. Co.'s proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows it to utilize telomerase-expressing regenerative pluripotent stem cell (PSC) for the manufacture of cell-based therapies to regenerate tissues afflicted with age-related chronic degenerative disease. Co.'s product candidates in the discovery stage include two cell-based therapies derived from telomerase-positive PSCs and two product candidates derived from its proprietary induced Tissue Regeneration technology. According to our AGE split history records, AgeX Therapeutics has had 6 splits.
AGE split history picture
AgeX Therapeutics (AGE) has 6 splits in our AGE split history database. The first split for AGE took place on May 12, 1986. This was a 3 for 2 split, meaning for each 2 shares of AGE owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 1500 share position following the split. AGE's second split took place on July 01, 1991. This was a 3 for 2 split, meaning for each 2 shares of AGE owned pre-split, the shareholder now owned 3 shares. For example, a 1500 share position pre-split, became a 2250 share position following the split. AGE's third split took place on April 01, 1992. This was a 5 for 4 split, meaning for each 4 shares of AGE owned pre-split, the shareholder now owned 5 shares. For example, a 2250 share position pre-split, became a 2812.5 share position following the split. AGE's 4th split took place on January 04, 1994. This was a 5 for 4 split, meaning for each 4 shares of AGE owned pre-split, the shareholder now owned 5 shares. For example, a 2812.5 share position pre-split, became a 3515.625 share position following the split. AGE's 5th split took place on October 01, 1997. This was a 3 for 2 split, meaning for each 2 shares of AGE owned pre-split, the shareholder now owned 3 shares. For example, a 3515.625 share position pre-split, became a 5273.4375 share position following the split. AGE's 6th split took place on March 15, 2024. This was a 28 for 1000 reverse split, meaning for each 1000 shares of AGE owned pre-split, the shareholder now owned 28 shares. For example, a 5273.4375 share position pre-split, became a 147.65625 share position following the split.

When a company such as AgeX Therapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as AgeX Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the AGE split history from start to finish, an original position size of 1000 shares would have turned into 147.65625 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AgeX Therapeutics shares, starting with a $10,000 purchase of AGE, presented on a split-history-adjusted basis factoring in the complete AGE split history. AGE split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/30/2018
End date: 03/18/2024
Start price/share: $192.86
End price/share: $16.90
Dividends collected/share: $0.00
Total return: -91.24%
Average Annual Total Return: -36.84%
Starting investment: $10,000.00
Ending investment: $876.23
Years: 5.30
Date Ratio
05/12/19863 for 2
07/01/19913 for 2
04/01/19925 for 4
01/04/19945 for 4
10/01/19973 for 2
03/15/202428 for 1000
AGE is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

AGEN Split History
AGLE Split History
AGN Split History
AGRX Split History
AGTI Split History
AHPI Split History
AIKI Split History
AIMD Split History
AIMT Split History
AIQ Split History

Email EnvelopeFree AGE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Intrusion Inc. (INTZ)
MicroSectorsTM Travel -3X Inverse Leveraged ETNs due May 29, 2042 (FLYD)
MicroSectorsTM FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038 (FNGD)
MicroSectorsTM FANG & Innovation -3X Inverse Leveraged ETNs due June 28, 2041 (BERZ)
ReWalk Robotics Ltd. (LFWD)
Outlook Therapeutics, Inc. (OTLK)
Aeva (AEVA)
Hempacco Co., Inc. (HPCO)
LM Funding America, Inc. (LMFA)
Texas Pacific Land Corporation (TPL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

AGE Insider Buying

AGE Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.